{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:23:31Z","timestamp":1740162211667,"version":"3.37.3"},"reference-count":161,"publisher":"Walter de Gruyter GmbH","issue":"8","funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"publisher","award":["81271476"],"award-info":[{"award-number":["81271476"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangzhou Science and Technology Plan Research Project","award":["201300000154"],"award-info":[{"award-number":["201300000154"]}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Natural Science Foundation","doi-asserted-by":"crossref","award":["2014A030310104"],"award-info":[{"award-number":["2014A030310104"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Alzheimer's disease (AD) is a common form of age-related dementia that mostly affects the aging population. Clinically, it is a disease characterized by impaired memory and progressive cognitive decline. Although the pathological hallmarks of AD have been traditionally described with a general confinement in the brain, recent studies have shown similar pathological changes in the retina, which is a developmental outgrowth of the forebrain. These AD-related neurodegenerative changes in the retina have been implicated to cause early visual problems in AD even before cognitive impairment becomes apparent. With recent advances in research, the commonly held view that AD-related cerebral pathology causes visual dysfunction through disruption of central visual pathways has been re-examined. Currently, several studies have already explored how AD manifests in the retina and the possibility of using the same retina as a window to non-invasively examine AD-related pathology in the brain. Non-invasive screening of AD through the retina has the potential to improve on early detection and management of the disease since the majority of AD cases are usually diagnosed very late. The purpose of this review is to provide evidence on the involvement of the retina in AD and to suggest a possible direction for future research into the non-invasive screening, diagnosis, and monitoring of AD using the retina.<\/jats:p>","DOI":"10.1515\/revneuro-2019-0119","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T17:15:02Z","timestamp":1604682902000},"page":"883-904","source":"Crossref","is-referenced-by-count":4,"title":["Retinal involvement in Alzheimer's disease (AD): evidence and current progress on the non-invasive diagnosis and monitoring of AD-related pathology using the eye"],"prefix":"10.1515","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7462-5482","authenticated-orcid":false,"given":"Fidelis","family":"Chibhabha","sequence":"first","affiliation":[{"name":"Department of Anatomy and Neurobiology , Zhongshan School of Medicine, Sun Yat-sen University , Guangzhou 510080 , China"},{"name":"Department of Anatomy, Faculty of Medicine , Midlands State University , P. Bag 9055, Senga , Gweru , Zimbabwe"},{"name":"and Guangdong Provincial Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-sen University , Guangzhou , 510080, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yaqi","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Neurobiology , Zhongshan School of Medicine, Sun Yat-sen University , Guangzhou 510080 , China"},{"name":"and Guangdong Provincial Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-sen University , Guangzhou , 510080, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Anatomy and Neurobiology , Zhongshan School of Medicine, Sun Yat-sen University , Guangzhou 510080 , China"},{"name":"and Guangdong Provincial Key Laboratory of Brain Function and Disease, Zhongshan School of Medicine, Sun Yat-sen University , Guangzhou , 510080, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"2023040102412667462_j_revneuro-2019-0119_ref_001_w2aab3b7b5b1b6b1ab2b1b1Aa","doi-asserted-by":"crossref","unstructured":"Alber, J., Goldfarb, D., Thompson, L.I., Arthur, E., Hernandez, K., Cheng, D., Debuc, D.C., Cordeiro, F., Provetti-Cunha, L., Den Haan, J., et al. (2020). Developing retinal biomarkers for the earliest stages of Alzheimer\u2019s disease: what we know, what we don\u2019t, and how to move forward. Alzheimers Dement. 16: 229\u2013243, https:\/\/doi.org\/10.1002\/alz.12006.","DOI":"10.1002\/alz.12006"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_002_w2aab3b7b5b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Albert, M.S., Dekosky, S.T., Dickson, D., Dubois, B., Feldman, H.H., Fox, N.C., Gamst, A., Holtzman, D.M., Jagust, W.J., Petersen, R.C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the national Institute on aging-alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7: 270\u2013279, https:\/\/doi.org\/10.1016\/j.jalz.2011.03.008.","DOI":"10.1016\/j.jalz.2011.03.008"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_003_w2aab3b7b5b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Alexandrov, P.N., Pogue, A., Bhattacharjee, S., and Lukiw, W.J. (2011). Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer\u2019s disease. Neuroreport 22: 623\u2013627, https:\/\/doi.org\/10.1097\/wnr.0b013e3283497334.","DOI":"10.1097\/WNR.0b013e3283497334"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_004_w2aab3b7b5b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association (2015). 2015 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 11: 332\u2013384.","DOI":"10.1016\/j.jalz.2015.02.003"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_005_w2aab3b7b5b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Amieva, H., Le Goff, M., Millet, X., Orgogozo, J.M., P\u00e9r\u00e8s, K., Barberger-Gateau, P., Jacqmin-Gadda, H., and Dartigues, J.F. (2008). Prodromal Alzheimer\u2019s disease: successive emergence of the clinical symptoms. Ann. Neurol. 64: 492\u2013498, https:\/\/doi.org\/10.1002\/ana.21509.","DOI":"10.1002\/ana.21509"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_006_w2aab3b7b5b1b6b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Anand-Apte, B., and Hollyfield, J. (2010). Developmental anatomy of the retinal and choroidal vasculature. In: DA, I.D. (Ed.), Encyclopedia of the eye. Oxford Academic Press, Oxford.","DOI":"10.1016\/B978-0-12-374203-2.00169-X"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_007_w2aab3b7b5b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Armstrong, R.A. (1996). Visual field defects in Alzheimer\u2019s disease patients may reflect differential pathology in the primary visual cortex. Optom. Vis. Sci. 73: 677\u2013682, https:\/\/doi.org\/10.1097\/00006324-199611000-00001.","DOI":"10.1097\/00006324-199611000-00001"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_008_w2aab3b7b5b1b6b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Asanad, S., Ross-Cisneros, F.N., Nassisi, M., Barron, E., Karanjia, R., and Sadun, A.A. (2019). The retina in Alzheimer\u2019s Disease: histomorphometric analysis of an ophthalmologic biomarker. Invest. Ophthalmol. Vis. Sci. 60: 1491\u20131500, https:\/\/doi.org\/10.1167\/iovs.18-25966.","DOI":"10.1167\/iovs.18-25966"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_009_w2aab3b7b5b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Attems, J., and Jellinger, K.A. (2014). The overlap between vascular disease and Alzheimer\u2019s disease\u2013lessons from pathology. BMC Med. 12: 206, https:\/\/doi.org\/10.1186\/s12916-014-0206-2.","DOI":"10.1186\/s12916-014-0206-2"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_010_w2aab3b7b5b1b6b1ab2b1c10Aa","doi-asserted-by":"crossref","unstructured":"Beach, T.G., Monsell, S.E., Phillips, L.E., and Kukull, W. (2012). Accuracy of the clinical diagnosis of alzheimer disease at national Institute on aging alzheimer disease centers, 2005-2010. J. Neuropathol. Exp. Neurol. 71: 266\u2013273, https:\/\/doi.org\/10.1097\/nen.0b013e31824b211b.","DOI":"10.1097\/NEN.0b013e31824b211b"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_011_w2aab3b7b5b1b6b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Berisha, F., Feke, G.T., Trempe, C.L., Mcmeel, J.W., and Schepens, C.L (2007). Retinal abnormalities in early Alzheimer\u2019s disease. Invest. Ophthalmol. Vis. Sci. 48: 2285\u20132289, https:\/\/doi.org\/10.1167\/iovs.06-1029.","DOI":"10.1167\/iovs.06-1029"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_012_w2aab3b7b5b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Blanks, J.C., Torigoe, Y., Hinton, D.R., and Blanks, R.H. (1996). Retinal pathology in Alzheimer\u2019s disease. I. Ganglion Cell loss in foveal\/parafoveal retina. Neurobiol. Aging 17: 377\u2013384, https:\/\/doi.org\/10.1016\/0197-4580(96)00010-3.","DOI":"10.1016\/0197-4580(96)00010-3"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_013_w2aab3b7b5b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Breteler, M.M. (2000). Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam study and the Rotterdam scan study. Ann. N. Y. Acad. Sci. 903: 457\u2013465, https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06399.x.","DOI":"10.1111\/j.1749-6632.2000.tb06399.x"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_014_w2aab3b7b5b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Brookmeyer, R., Johnson, E., Ziegler-Graham, K., and Arrighi, H.M. (2007). Forecasting the global burden of Alzheimer\u2019s disease. Alzheimers Dement. 3: 186\u2013191, https:\/\/doi.org\/10.1016\/j.jalz.2007.04.381.","DOI":"10.1016\/j.jalz.2007.04.381"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_015_w2aab3b7b5b1b6b1ab2b1c15Aa","doi-asserted-by":"crossref","unstructured":"Bruban, J., Glotin, A.L., Dinet, V., Chalour, N., Sennlaub, F., Jonet, L., An, N., Faussat, A.M., and Mascarelli, F. (2009). Amyloid-\u03b2(1-42) alters structure and function of retinal pigmented epithelial cells. Aging Cell 8: 162\u2013177, https:\/\/doi.org\/10.1111\/j.1474-9726.2009.00456.x.","DOI":"10.1111\/j.1474-9726.2009.00456.x"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_016_w2aab3b7b5b1b6b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Bull, N.D., Guidi, A., Goedert, M., Martin, K.R., and Spillantini, M.G. (2012). Reduced axonal transport and increased excitotoxic retinal ganglion cell degeneration in mice transgenic for human mutant P301S tau. PloS One 7: E34724, https:\/\/doi.org\/10.1371\/journal.pone.0034724.","DOI":"10.1371\/journal.pone.0034724"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_017_w2aab3b7b5b1b6b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"Bulut, M., Kurtulu\u015f, F., G\u00f6zkaya, O., Erol, M.K., Cengiz, A., Ak\u0131dan, M., and Yaman, A. (2018). Evaluation of optical coherence tomography angiographic findings in Alzheimer\u2019s type dementia. Br. J. Ophthalmol. 102: 233\u2013237, https:\/\/doi.org\/10.1136\/bjophthalmol-2017-310476.","DOI":"10.1136\/bjophthalmol-2017-310476"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_018_w2aab3b7b5b1b6b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Cabrera Debuc, D., Gaca-Wysocka, M., Grzybowsk, I.A., and Kanclerz, P. (2019). Identification of retinal biomarkers in Alzheimer\u2019s disease using optical coherence tomography: recent insights, challenges, and opportunities. J. Clin. Med. 8: 996, https:\/\/doi.org\/10.3390\/jcm8070996.","DOI":"10.3390\/jcm8070996"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_019_w2aab3b7b5b1b6b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"Campbell, M.C.W., De Vries, D., Emptage, L., Cookson, C., Kisilak, M., Bueno, J.M., and Avila, F.J. (2015). Polarization properties of amyloid beta in the retina of the eye as a biomarker of Alzheimer\u2019s disease. In: Optics in the life sciences. Optical Society of America, Vancouver.","DOI":"10.1364\/BODA.2015.BM3A.4"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_020_w2aab3b7b5b1b6b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"Catchpole, I., Germaschewski, V., Hoh Kam, J., Lundh Von Leithner, P., Ford, S., Gough, G., Adamson, P., Overend, P., Hilpert, J., et al. (2013). Systemic administration of abeta mab reduces retinal deposition of abeta and activated complement C3 in age-related macular degeneration mouse model. PloS One 8: E65518, https:\/\/doi.org\/10.1371\/journal.pone.0065518.","DOI":"10.1371\/journal.pone.0065518"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_021_w2aab3b7b5b1b6b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Chan, V.T.T., Sun, Z., Tang, S., Chen, L.J., Wong, A., Tham, C.C., Wong, T.Y., Chen, C., Ikram, M.K., et al. (2019). spectral-domain OCT measurements in Alzheimer\u2019s disease: a systematic review and meta-analysis. Ophthalmology 126: 497\u2013510, https:\/\/doi.org\/10.1016\/j.ophtha.2018.08.009.","DOI":"10.1016\/j.ophtha.2018.08.009"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_022_w2aab3b7b5b1b6b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"Chang, L.Y., Lowe, J., Ardiles, A., Lim, J., Grey, A.C., Robertson, K., Danesh-Meyer, H., Palacios, A.G., and Acosta, M.L. (2014). Alzheimer\u2019s disease in the human eye. clinical tests that identify ocular and visual information processing deficit as Biomarkers. Alzheimers Dement. 10: 251\u201361, https:\/\/doi.org\/10.1016\/j.jalz.2013.06.004.","DOI":"10.1016\/j.jalz.2013.06.004"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_023_w2aab3b7b5b1b6b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"Cheung, C.Y., Ong, Y.T., Ikram, M.K., Ong, S.Y., Li, X., Hilal, S., Catindig, J.A., Venketasubramanian, N., Yap, P., Seow, D., et al. (2014). Microvascular network alterations in the retina of patients with Alzheimer\u2019s disease. Alzheimers Dement. 10: 135\u2013142, https:\/\/doi.org\/10.1016\/j.jalz.2013.06.009.","DOI":"10.1016\/j.jalz.2013.06.009"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_024_w2aab3b7b5b1b6b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"Chiasseu, M., Alarcon-Martinez, L., Belforte, N., Quintero, H., Dotigny, F., Destroismaisons, L, Vande velde, C., Panayi, F., Louis, C, and Di Polo, A. (2017). Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer\u2019s disease. Mol. Neurodegener. 12: 58, https:\/\/doi.org\/10.1186\/s13024-017-0199-3.","DOI":"10.1186\/s13024-017-0199-3"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_025_w2aab3b7b5b1b6b1ab2b1c25Aa","doi-asserted-by":"crossref","unstructured":"Chibhabha, F., Yang, Y., Ying, K., Jia, F., Zhang, Q., Ullah, S., Liang, Z., Xie, M., and Li, F. (2020). Non-invasive optical imaging of retinal A\u03b2 plaques using curcumin loaded polymeric micelles in APPswe\/PS1\u0394E9 transgenic mice for the diagnosis of Alzheimer\u2019s disease. J. Mater. Chem. B., https:\/\/doi.org\/10.1039\/D0TB01101K.","DOI":"10.1039\/D0TB01101K"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_026_w2aab3b7b5b1b6b1ab2b1c26Aa","doi-asserted-by":"crossref","unstructured":"Chiquita, S., Campos, E.J., Castelhano, J., Ribeiro, M., Sereno, J., Moreira, P.I., Castelo-Branco, M., and Ambr\u00f3sio, A.F. (2019). Retinal thinning of inner sub-layers is associated with cortical atrophy in a mouse model of Alzheimer\u2019s disease: a longitudinal multimodal in vivo study. Alzheimer\u2019s Res. Ther. 11: 90, https:\/\/doi.org\/10.1186\/s13195-019-0542-8.","DOI":"10.1186\/s13195-019-0542-8"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_027_w2aab3b7b5b1b6b1ab2b1c27Aa","doi-asserted-by":"crossref","unstructured":"Coppola, G., Di Renzo, A., Ziccardi, L., Martelli, F., Fadda, A., Manni, G., Barboni, P., Pierelli, F., Sadun, A.A., and Parisi, V. (2015). Optical coherence tomography in Alzheimer\u2019s Disease: a meta-analysis. PloS One 10: E0134750, https:\/\/doi.org\/10.1371\/journal.pone.0134750.","DOI":"10.1371\/journal.pone.0134750"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_028_w2aab3b7b5b1b6b1ab2b1c28Aa","doi-asserted-by":"crossref","unstructured":"Cunha, J.P., Proen\u00e7a, R., Dias-Santos, A., Melancia, D., Almeida, R., \u00c1guas, H., Santos, B.O., Alves, M., Ferreira, J., Papoila, A.L., et al. (2017). Choroidal thinning: Alzheimer\u2019s disease and aging. Alzheimers Dement (Amst). 8: 11\u201317, https:\/\/doi.org\/10.1016\/j.dadm.2017.03.004.","DOI":"10.1016\/j.dadm.2017.03.004"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_029_w2aab3b7b5b1b6b1ab2b1c29Aa","doi-asserted-by":"crossref","unstructured":"Danesh-Meyer, H.V., Birch, H., Ku, J.Y., Carroll, S., and Gamble, G. (2006). Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging. Neurology 67: 1852\u20131854, https:\/\/doi.org\/10.1212\/01.wnl.0000244490.07925.8b.","DOI":"10.1212\/01.wnl.0000244490.07925.8b"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_030_w2aab3b7b5b1b6b1ab2b1c30Aa","doi-asserted-by":"crossref","unstructured":"Davies, D.C., Mccoubrie, P., Mcdonald, B., and Jobst, K.A. (1995). Myelinated axon number in the optic nerve is unaffected by Alzheimer\u2019s disease. Br. J. Ophthalmol. 79: 596\u2013600, https:\/\/doi.org\/10.1136\/bjo.79.6.596.","DOI":"10.1136\/bjo.79.6.596"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_031_w2aab3b7b5b1b6b1ab2b1c31Aa","doi-asserted-by":"crossref","unstructured":"de Jong, F.J., Schrijvers, E.M., Ikram, M.K., Koudstaal, P.J., de Jong, P.T., Hofman, A., Vingerling, J.R., and Breteler, M.M. (2011). Retinal vascular caliber and risk of dementia: the Rotterdam Study. Neurology 76: 816\u2013821, https:\/\/doi.org\/10.1212\/wnl.0b013e31820e7baa.","DOI":"10.1212\/WNL.0b013e31820e7baa"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_032_w2aab3b7b5b1b6b1ab2b1c32Aa","doi-asserted-by":"crossref","unstructured":"De La Torre, J.C. (2002). Alzheimer disease as a vascular disorder: nosological evidence. Stroke 33: 1152\u20131162, https:\/\/doi.org\/10.1161\/01.str.0000014421.15948.67.","DOI":"10.1161\/01.STR.0000014421.15948.67"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_033_w2aab3b7b5b1b6b1ab2b1c33Aa","doi-asserted-by":"crossref","unstructured":"Ding, J.D., Lin, J., Mace, B.E., Herrmann, R., Sullivan, P., and Bowes Rickman, C. (2008). Targeting age-related macular degeneration with Alzheimer\u2019s disease based immunotherapies: anti-amyloid-\u03b2 antibody attenuates pathologies in an age-related macular degeneration mouse model. Vis. Res. 48: 339\u2013345, https:\/\/doi.org\/10.1016\/j.visres.2007.07.025.","DOI":"10.1016\/j.visres.2007.07.025"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_034_w2aab3b7b5b1b6b1ab2b1c34Aa","doi-asserted-by":"crossref","unstructured":"Dutescu, R.M., Li, Q.X., Crowston, J., Masters, C.L., Baird, P.N., and Culvenor, J.G. (2009). Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer\u2019s disease. Graefes Arch. Clin. Exp. Ophthalmol. 247: 1213\u20131221, https:\/\/doi.org\/10.1007\/s00417-009-1060-3.","DOI":"10.1007\/s00417-009-1060-3"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_035_w2aab3b7b5b1b6b1ab2b1c35Aa","doi-asserted-by":"crossref","unstructured":"Dysli, C., Wolf, S., Berezin, M.Y., Sauer, L., Hammer, M., and Zinkernagel, M.S. (2017). Fluorescence lifetime imaging ophthalmoscopy. Prog. Retin. Eye Res. 60: 120\u2013143, https:\/\/doi.org\/10.1016\/j.preteyeres.2017.06.005.","DOI":"10.1016\/j.preteyeres.2017.06.005"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_036_w2aab3b7b5b1b6b1ab2b1c36Aa","doi-asserted-by":"crossref","unstructured":"Eliasdottir, T.S. (2018). Retinal oximetry and systemic arterial oxygen levels. Acta Ophthalmol. A113: 1\u201344, https:\/\/doi.org\/10.1111\/aos.13932.","DOI":"10.1111\/aos.13932"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_037_w2aab3b7b5b1b6b1ab2b1c37Aa","doi-asserted-by":"crossref","unstructured":"Farias, S.T., Mungas, D., Reed, B.R., Harvey, D., Cahn-Weiner, D., and Decarli, C. (2006). MCI is associated with deficits in everyday functioning. Alzheimer Dis. Assoc. Disord. 20: 217\u2013223, https:\/\/doi.org\/10.1097\/01.wad.0000213849.51495.d9.","DOI":"10.1097\/01.wad.0000213849.51495.d9"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_038_w2aab3b7b5b1b6b1ab2b1c38Aa","doi-asserted-by":"crossref","unstructured":"Farrell, M.E., Kennedy, K.M., Rodrigue, K.M., Wig, G., Bischof, G.N., Rieck, J.R., Chen, X., Festini, S.B., Devous, M.D., and Park, D.C. (2017). Association of longitudinal cognitive decline with amyloid burden in middle-aged and older adults: evidence for a dose-response relationship. JAMA Neurol. 74: 830\u2013838, https:\/\/doi.org\/10.1001\/jamaneurol.2017.0892.","DOI":"10.1001\/jamaneurol.2017.0892"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_039_w2aab3b7b5b1b6b1ab2b1c39Aa","doi-asserted-by":"crossref","unstructured":"Feke, G.T., Hyman, B.T., Stern, R.A., and Pasquale, L.R. (2015). Retinal blood flow in mild cognitive impairment and Alzheimer\u2019s disease. Alzheimers Dement (Amst). 1: 144\u2013151, https:\/\/doi.org\/10.1016\/j.dadm.2015.01.004.","DOI":"10.1016\/j.dadm.2015.01.004"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_040_w2aab3b7b5b1b6b1ab2b1c40Aa","doi-asserted-by":"crossref","unstructured":"Fletcher, W.A. and Sharpe, J.A. (1986). Saccadic eye movement dysfunction in Alzheimer\u2019s disease. Ann. Neurol. 20: 464\u2013471, https:\/\/doi.org\/10.1002\/ana.410200405.","DOI":"10.1002\/ana.410200405"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_041_w2aab3b7b5b1b6b1ab2b1c41Aa","doi-asserted-by":"crossref","unstructured":"Frederikse, P.H. (2000). Amyloid-like protein structure in mammalian ocular lenses. Curr. Eye Res. 20: 462\u2013468, https:\/\/doi.org\/10.1076\/0271-3683(200006)2061-yft462.","DOI":"10.1076\/0271-3683(200006)2061-YFT462"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_042_w2aab3b7b5b1b6b1ab2b1c42Aa","doi-asserted-by":"crossref","unstructured":"Frost, S., Martins, R.N., and Kanagasingam, Y. (2010). Ocular biomarkers for early detection of Alzheimer\u2019s disease. J Alzheimers Dis. 22: 1\u201316, https:\/\/doi.org\/10.3233\/jad-2010-100819.","DOI":"10.3233\/JAD-2010-100819"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_043_w2aab3b7b5b1b6b1ab2b1c43Aa","doi-asserted-by":"crossref","unstructured":"Frost, S., Kanagasingam, Y., Sohrabi, H., Vignarajan, J., Bourgeat, P., Salvado, O., Villemagne, V., Rowe, C.C., Macaulay, S.L., Szoeke, C., et al. (2013). Retinal vascular biomarkers for early detection and monitoring of Alzheimer\u2019s disease. Transl. Psychiatry 3: E233, https:\/\/doi.org\/10.1038\/tp.2012.150.","DOI":"10.1038\/tp.2012.150"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_044_w2aab3b7b5b1b6b1ab2b1c44Aa","doi-asserted-by":"crossref","unstructured":"Gao, S.S., Jia, Y., Zhang, M., Su, J.P., Liu, G., Hwang, T.S., Bailey, S.T., and Huang, D. (2016). Optical coherence tomography angiography. Invest. Ophthalmol. Vis. Sci. 57: 27\u201336, https:\/\/doi.org\/10.1167\/iovs.15-19043.","DOI":"10.1167\/iovs.15-19043"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_045_w2aab3b7b5b1b6b1ab2b1c45Aa","doi-asserted-by":"crossref","unstructured":"Gasparini, L., Crowther, R.A., Martin, K.R., Berg, N., Coleman, M., Goedert, M., and Spillantini, M.G. (2011). Tau inclusions in retinal ganglion cells of human P301S tau transgenic Mice: effects on axonal viability. Neurobiol. Aging 32: 419\u2013433, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2009.03.002.","DOI":"10.1016\/j.neurobiolaging.2009.03.002"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_046_w2aab3b7b5b1b6b1ab2b1c46Aa","doi-asserted-by":"crossref","unstructured":"Georgevsky, D., Retsas, S., Raoufi, N., Shimoni, O., and Golzan, S.M. (2019). A longitudinal assessment of retinal function and structure in the APP\/PS1 transgenic mouse model of Alzheimer\u2019s disease. Transl. Neurodegener. 8: 30, https:\/\/doi.org\/10.1186\/s40035-019-0170-z.","DOI":"10.1186\/s40035-019-0170-z"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_047_w2aab3b7b5b1b6b1ab2b1c47Aa","doi-asserted-by":"crossref","unstructured":"Goldstein, L.E., Muffat, J.A., Cherny, R.A., Moir, R.D., Ericsson, M.H., Huang, X., Mavros, C., Coccia, J.A., Faget, K.Y., Fitch, K.A., et al. (2003). Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer\u2019s disease. Lancet 361: 1258\u20131265, https:\/\/doi.org\/10.1016\/s0140-6736(03)12981-9.","DOI":"10.1016\/S0140-6736(03)12981-9"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_048_w2aab3b7b5b1b6b1ab2b1c48Aa","doi-asserted-by":"crossref","unstructured":"Golzan, S.M., Goozee, K., Georgevsky, D., Avolio, A., Chatterjee, P., Shen, K., Gupta, V., Chung, R., Savage, G., Orr, C.F., et al. (2017). Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer\u2019s disease. Alzheimer\u2019s Res. Ther. 9: 13, https:\/\/doi.org\/10.1186\/s13195-017-0239-9.","DOI":"10.1186\/s13195-017-0239-9"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_049_w2aab3b7b5b1b6b1ab2b1c49Aa","doi-asserted-by":"crossref","unstructured":"Goudsmit, M., Van Campen, J., Schilt, T., Hinnen, C., Franzen, S., and Schmand, B. (2018). One size does not fit all: comparative diagnostic accuracy of the rowland universal dementia assessment scale And the mini mental state examination in A memory clinic population with very low education. Dement Geriatr Cogn Dis Extra. 8: 290\u2013305, https:\/\/doi.org\/10.1159\/000490174.","DOI":"10.1159\/000490174"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_050_w2aab3b7b5b1b6b1ab2b1c50Aa","doi-asserted-by":"crossref","unstructured":"Govindpani, K., Vinnakota, C., Waldvogel, H.J., Faull, R.L., and Kwakowsky, A. (2020). Vascular dysfunction in Alzheimer\u2019s disease: a biomarker of disease progression and A potential therapeutic target. Neural Regen Res. 15: 1030\u20131032.","DOI":"10.4103\/1673-5374.270306"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_051_w2aab3b7b5b1b6b1ab2b1c51Aa","doi-asserted-by":"crossref","unstructured":"Grayson, A.S., Weiler, E.M., and Sandman, D.E. (1995). Visual evoked potentials in early Alzheimer\u2019s dementia: an exploratory study. J. Gen. Psychol. 122: 113\u2013129, https:\/\/doi.org\/10.1080\/00221309.1995.9921226.","DOI":"10.1080\/00221309.1995.9921226"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_052_w2aab3b7b5b1b6b1ab2b1c52Aa","doi-asserted-by":"crossref","unstructured":"Grienberger, C., Rochefort, N.L., Adelsberger, H., Henning, H.A., Hill, D.N., Reichwald, J., Staufenbiel, M., and Konnerth, A. (2012). Staged decline of neuronal function in vivo in an animal model of Alzheimer\u2019s disease. Nat. Commun. 3: 774, https:\/\/doi.org\/10.1038\/ncomms1783.","DOI":"10.1038\/ncomms1783"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_053_w2aab3b7b5b1b6b1ab2b1c53Aa","doi-asserted-by":"crossref","unstructured":"Guo, L., Duggan, J., and Cordeiro, M.F. (2010). Alzheimer\u2019s disease and retinal neurodegeneration. Curr. Alzheimer Res. 7: 3\u201314, https:\/\/doi.org\/10.2174\/156720510790274491.","DOI":"10.2174\/156720510790274491"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_054_w2aab3b7b5b1b6b1ab2b1c54Aa","doi-asserted-by":"crossref","unstructured":"Gupta, V.K., Chitranshi, N., Gupta, V.B., Golzan, M., Dheer, Y., Wall, R.V., Georgevsky, D., King, A.E., Vickers, J.C., Chung, R., et al. (2016). Amyloid \u03b2 accumulation and inner retinal degenerative changes in Alzheimer\u2019s Disease transgenic mouse. Neurosci. Lett. 623: 52\u20136, https:\/\/doi.org\/10.1016\/j.neulet.2016.04.059.","DOI":"10.1016\/j.neulet.2016.04.059"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_055_w2aab3b7b5b1b6b1ab2b1c55Aa","doi-asserted-by":"crossref","unstructured":"Haan, J.D., Van De Kreeke, J.A., Berckel, V, Barkhof, F., Teunissen, C.E., Scheltens, P., Verbraak, F.D., and Bouwman, F.H. (2019). Is retinal vasculature a biomarker in amyloid proven Alzheimer\u2019s disease?. Alzheimer\u2019s Dementia 11: 383\u2013391, https:\/\/doi.org\/10.1016\/j.dadm.2019.03.006.","DOI":"10.1016\/j.dadm.2019.03.006"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_056_w2aab3b7b5b1b6b1ab2b1c56Aa","doi-asserted-by":"crossref","unstructured":"Hadoux, X., Hui, F., Lim, J.K.H., Masters, C.L., P\u00e9bay, A., Chevalier, S., Ha, J., Loi, S., Fowler, C.J., Rowe, C., et al. (2019). Non-invasive in vivo hyperspectral imaging of the retina for potential biomarker use in Alzheimer\u2019s disease. Nat. Commun. 10: 4227, https:\/\/doi.org\/10.1038\/s41467-019-12242-1.","DOI":"10.1038\/s41467-019-12242-1"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_057_w2aab3b7b5b1b6b1ab2b1c57Aa","doi-asserted-by":"crossref","unstructured":"Hagag, A.M., Gao, S.S., Jia, Y., and Huang, D. (2017). Optical coherence tomography angiography: technical principles and clinical applications in ophthalmology. Taiwan J Ophthalmol. 7: 115\u2013129.","DOI":"10.4103\/tjo.tjo_31_17"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_058_w2aab3b7b5b1b6b1ab2b1c58Aa","doi-asserted-by":"crossref","unstructured":"Harper, D.J., Augustin, M., Lichtenegger, A., Gesperger, J., Himmel, T., Muck, M., Merkle, C.W., Eugui, P., Kummer, S., Woehrer, A., et al. (2020). Retinal analysis of a mouse model of Alzheimer\u2019s disease with multicontrast optical coherence tomography. Neurophotonics 7: 015006, https:\/\/doi.org\/10.1117\/1.nph.7.1.015006.","DOI":"10.1117\/1.NPh.7.1.015006"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_059_w2aab3b7b5b1b6b1ab2b1c59Aa","doi-asserted-by":"crossref","unstructured":"Hart, N.J., Koronyo, Y., Black, K.L., and Koronyo-Hamaoui, M. (2016). Ocular indicators of Alzheimer\u2019s: exploring disease in the retina. Acta Neuropathol. 132: 767\u2013787, https:\/\/doi.org\/10.1007\/s00401-016-1613-6.","DOI":"10.1007\/s00401-016-1613-6"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_060_w2aab3b7b5b1b6b1ab2b1c60Aa","doi-asserted-by":"crossref","unstructured":"Hedges, T.R.3rd, Perez Galves, R., Speigelman, D., Barbas, N.R., Peli, E., and Yardley, C.J. (1996). Retinal nerve fiber layer abnormalities in Alzheimer\u2019s disease. Acta Ophthalmol. Scand. 74: 271\u2013275.","DOI":"10.1111\/j.1600-0420.1996.tb00090.x"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_061_w2aab3b7b5b1b6b1ab2b1c61Aa","doi-asserted-by":"crossref","unstructured":"Hinton, D.R., Sadun, A.A., Blanks, J.C., and Miller, C.A. (1986). Optic-nerve degeneration in Alzheimer\u2019s disease. N. Engl. J. Med. 315: 485\u2013487, https:\/\/doi.org\/10.1056\/nejm198608213150804.","DOI":"10.1056\/NEJM198608213150804"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_062_w2aab3b7b5b1b6b1ab2b1c62Aa","doi-asserted-by":"crossref","unstructured":"Ho, C.Y., Troncoso, J.C., Knox, D., Stark, W., and Eberhart, C.G. (2014). \u03b2-Amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer\u2019s and Parkinson\u2019s disease patients. Brain Pathol. 24: 25\u201332, https:\/\/doi.org\/10.1111\/bpa.12070.","DOI":"10.1111\/bpa.12070"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_063_w2aab3b7b5b1b6b1ab2b1c63Aa","doi-asserted-by":"crossref","unstructured":"Hoar, R.M. (1982). Embryology of the eye. Environ. Health Perspect. 44: 31\u20134, https:\/\/doi.org\/10.1289\/ehp.824431.","DOI":"10.1289\/ehp.824431"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_064_w2aab3b7b5b1b6b1ab2b1c64Aa","doi-asserted-by":"crossref","unstructured":"Hyman, B.T., Phelps, C.H., Beach, T.G., Bigio, E.H., Cairns, N.J., Carrillo, M.C., Dickson, D.W., Duyckaerts, C., Frosch, M.P., Masliah, E., et al. (2012). National Institute on aging-alzheimer\u2019s association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement. 8: 1\u201313, https:\/\/doi.org\/10.1016\/j.jalz.2011.10.007.","DOI":"10.1016\/j.jalz.2011.10.007"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_065_w2aab3b7b5b1b6b1ab2b1c65Aa","doi-asserted-by":"crossref","unstructured":"Iseri, P.K., Altinas, O., Tokay, T., and Yuksel, N. (2006). Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J. Neuro Ophthalmol. 26: 18\u201324, https:\/\/doi.org\/10.1097\/01.wno.0000204645.56873.26.","DOI":"10.1097\/01.wno.0000204645.56873.26"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_066_w2aab3b7b5b1b6b1ab2b1c66Aa","doi-asserted-by":"crossref","unstructured":"Jiang, H., Wei, Y., Shi, Y., Wright, C.B., Sun, X., Gregori, G., Zheng, F., Vanner, E.A., Lam, B.L., Rundek, T., et al. (2018). Altered macular microvasculature in mild cognitive impairment and Alzheimer disease. J. Neuro Ophthalmol. 38: 292\u2013298, https:\/\/doi.org\/10.1097\/wno.0000000000000580.","DOI":"10.1097\/WNO.0000000000000580"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_067_w2aab3b7b5b1b6b1ab2b1c67Aa","doi-asserted-by":"crossref","unstructured":"Jonas, J.B. and Dichtl, A. (1996). Evaluation of the retinal nerve fiber layer. Surv. Ophthalmol. 40: 369\u2013378, https:\/\/doi.org\/10.1016\/s0039-6257(96)80065-8.","DOI":"10.1016\/S0039-6257(96)80065-8"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_068_w2aab3b7b5b1b6b1ab2b1c68Aa","doi-asserted-by":"crossref","unstructured":"Karantzoulis, S. and Galvin, J.E. (2011). Distinguishing Alzheimer\u2019s disease from other major forms of dementia. Expert Rev. Neurother. 11: 1579\u20131591, https:\/\/doi.org\/10.1586\/ern.11.155.","DOI":"10.1586\/ern.11.155"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_069_w2aab3b7b5b1b6b1ab2b1c69Aa","doi-asserted-by":"crossref","unstructured":"Katz, B. and Rimmer, S. (1989). Ophthalmologic manifestations of Alzheimer\u2019s disease. Surv. Ophthalmol. 34: 31\u201343, https:\/\/doi.org\/10.1016\/0039-6257(89)90127-6.","DOI":"10.1016\/0039-6257(89)90127-6"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_070_w2aab3b7b5b1b6b1ab2b1c70Aa","doi-asserted-by":"crossref","unstructured":"Kayabasi, U. (2014). Retinal Examination for the diagnosis of Alzheimer\u2019s disease. Int J Ophthalmol Clin Res. 1: 1, https:\/\/doi.org\/10.23937\/2378-346x\/1410002.","DOI":"10.23937\/2378-346X\/1410002"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_071_w2aab3b7b5b1b6b1ab2b1c71Aa","doi-asserted-by":"crossref","unstructured":"Kerbage, C., Sadowsky, C.H., Jennings, D., Cagle, G.D., and Hartung, P.D. (2013). Alzheimer\u2019s disease diagnosis by detecting exogenous fluorescent signal of ligand bound to beta amyloid in the lens of human eye: an exploratory study. Front. Neurol. 4: 62, https:\/\/doi.org\/10.3389\/fneur.2013.00062.","DOI":"10.3389\/fneur.2013.00062"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_072_w2aab3b7b5b1b6b1ab2b1c72Aa","doi-asserted-by":"crossref","unstructured":"Kerbage, C., Sadowsky, C.H., Tariot, P.N., Agronin, M., Alva, G., Turner, F.D., Nilan, D., Cameron, A., Cagle, G.D., and Hartung, P.D. (2015). Detection of amyloid beta signature in the lens and its correlation in the brain to aid in the diagnosis of Alzheimer\u2019s disease. Am J Alzheimers Dis Other Demen. 30: 738\u2013745, https:\/\/doi.org\/10.1177\/1533317513520214.","DOI":"10.1177\/1533317513520214"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_073_w2aab3b7b5b1b6b1ab2b1c73Aa","doi-asserted-by":"crossref","unstructured":"Kergoat, H., Kergoat, M.J., Justino, L., Chertkow, H., Robillard, A., and Bergman, H. (2001). An evaluation of the retinal nerve fiber layer thickness by scanning laser polarimetry in individuals with dementia of the Alzheimer type. Acta Ophthalmol. Scand. 79: 187\u2013191, https:\/\/doi.org\/10.1034\/j.1600-0420.2001.079002187.x.","DOI":"10.1034\/j.1600-0420.2001.079002187.x"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_074_w2aab3b7b5b1b6b1ab2b1c74Aa","doi-asserted-by":"crossref","unstructured":"Kesler, A., Vakhapova, V., Korczyn, A.D., Naftaliev, E., and Neudorfer, M. (2011). Retinal thickness in patients with mild cognitive impairment and Alzheimer\u2019s disease. Clin. Neurol. Neurosurg. 113: 523\u2013526, https:\/\/doi.org\/10.1016\/j.clineuro.2011.02.014.","DOI":"10.1016\/j.clineuro.2011.02.014"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_075_w2aab3b7b5b1b6b1ab2b1c75Aa","doi-asserted-by":"crossref","unstructured":"Kim, J.I. and Kang, B.H. (2019). Decreased retinal thickness in patients with Alzheimer\u2019s disease is correlated with disease severity. PloS One 14: E0224180, https:\/\/doi.org\/10.1371\/journal.pone.0224180.","DOI":"10.1371\/journal.pone.0224180"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_076_w2aab3b7b5b1b6b1ab2b1c76Aa","doi-asserted-by":"crossref","unstructured":"Koronyo, Y., Salumbides, B.C., Black, K.L., and Koronyo-Hamaoui, M. (2012). Alzheimer\u2019s disease in the retina: imaging retinal abeta plaques for early diagnosis and therapy assessment. Neurodegener. Dis. 10: 285\u2013293, https:\/\/doi.org\/10.1159\/000335154.","DOI":"10.1159\/000335154"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_077_w2aab3b7b5b1b6b1ab2b1c77Aa","doi-asserted-by":"crossref","unstructured":"Koronyo, Y., Biggs, D., Barron, E., Boyer, D.S., Pearlman, J.A., Au, W.J., Kile, S.J., Blanco, A., Fuchs, D.T., Ashfaq, A., et al. (2017). Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight. 2: e93621, https:\/\/doi.org\/10.1172\/jci.insight.93621.","DOI":"10.1172\/jci.insight.93621"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_078_w2aab3b7b5b1b6b1ab2b1c78Aa","doi-asserted-by":"crossref","unstructured":"Koronyo-Hamaoui, M., Koronyo, Y., Ljubimov, A.V., Miller, C.A., Ko, M.K., Black, K.L., Schwartz, M., and Farkas, D.L. (2011). Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in A mouse model. Neuroimage 1: S204\u2013S217, https:\/\/doi.org\/10.1016\/j.neuroimage.2010.06.020.","DOI":"10.1016\/j.neuroimage.2010.06.020"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_079_w2aab3b7b5b1b6b1ab2b1c79Aa","doi-asserted-by":"crossref","unstructured":"Krasodomska, K., Lubi\u0144ski, W., Potemkowski, A., and Honczarenko, K. (2010). Pattern electroretinogram (PERG) and pattern visual evoked potential (PVEP) in the early stages of Alzheimer\u2019s disease. Doc. Ophthalmol. 121: 111\u2013121, https:\/\/doi.org\/10.1007\/s10633-010-9238-x.","DOI":"10.1007\/s10633-010-9238-x"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_080_w2aab3b7b5b1b6b1ab2b1c80Aa","doi-asserted-by":"crossref","unstructured":"Kromer, R., Serbecic, N., Hausner, L., Froelich, L., Aboul-enein, F., and Beutelspacher, S.C. (2014). Detection of retinal nerve fiber layer defects in Alzheimer\u2019s disease using SD-OCT. Front. Psychiatr. 5: 22, https:\/\/doi.org\/10.3389\/fpsyt.2014.00022.","DOI":"10.3389\/fpsyt.2014.00022"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_081_w2aab3b7b5b1b6b1ab2b1c81Aa","doi-asserted-by":"crossref","unstructured":"La Morgia, C., Ross-Cisneros, F.N., Koronyo, Y., Hannibal, J., Gallassi, R., Cantalupo, G., Sambati, L., Pan, B.X., Tozer, K.R., Barboni, P., et al. (2016). Melanopsin retinal ganglion cell loss in alzheimer disease. Ann. Neurol. 79: 90\u2013109, https:\/\/doi.org\/10.1002\/ana.24548.","DOI":"10.1002\/ana.24548"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_082_w2aab3b7b5b1b6b1ab2b1c82Aa","doi-asserted-by":"crossref","unstructured":"Lahme, L., Esser, E.L., Mihailovic, N., Schubert, F., Lauermann, J., Johnen, A., Eter, N., Duning, T., and Alnawaiseh, M. (2018). Evaluation of ocular perfusion in Alzheimer\u2019s disease using optical coherence tomography angiography. J Alzheimers Dis. 66: 1745\u20131752, https:\/\/doi.org\/10.3233\/jad-180738.","DOI":"10.3233\/JAD-180738"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_083_w2aab3b7b5b1b6b1ab2b1c83Aa","doi-asserted-by":"crossref","unstructured":"Larrosa, J.M., Garcia-Martin, E., Bambo, M.P., Pinilla, J., Polo, V., Otin, S., Satue, M., Herrero, R., and Pablo, L.E. (2014). Potential new diagnostic tool for Alzheimer\u2019s disease using a linear discriminant function for fourier domain optical coherence tomography. Invest. Ophthalmol. Vis. Sci. 55: 3043\u201351, https:\/\/doi.org\/10.1167\/iovs.13-13629.","DOI":"10.1167\/iovs.13-13629"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_084_w2aab3b7b5b1b6b1ab2b1c84Aa","doi-asserted-by":"crossref","unstructured":"Lee, C.S. and Apte, R.S. (2020). Retinal biomarkers of Alzheimer\u2019s disease. Am. J. Ophthalmol., https:\/\/doi.org\/10.1016\/j.ajo.2020.04.040.","DOI":"10.1016\/j.ajo.2020.04.040"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_085_w2aab3b7b5b1b6b1ab2b1c85Aa","doi-asserted-by":"crossref","unstructured":"Leger, F., Fernagut, P.O., Canron, M.H., L\u00e9oni, S., Vital, C., Tison, F., Bezard, E., and Vital, A. (2011). Protein aggregation in the aging retina. J. Neuropathol. Exp. Neurol. 70: 63\u20138, https:\/\/doi.org\/10.1097\/nen.0b013e31820376cc.","DOI":"10.1097\/NEN.0b013e31820376cc"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_086_w2aab3b7b5b1b6b1ab2b1c86Aa","doi-asserted-by":"crossref","unstructured":"Leitgeb, R.A., Werkmeister, R.M., Blatter, C., and Schmetterer, L. (2014). Doppler optical coherence tomography. Prog. Retin. Eye Res. 41: 26\u201343, https:\/\/doi.org\/10.1016\/j.preteyeres.2014.03.004.","DOI":"10.1016\/j.preteyeres.2014.03.004"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_087_w2aab3b7b5b1b6b1ab2b1c87Aa","doi-asserted-by":"crossref","unstructured":"Li, L., Luo, J., Chen, D., Tong, J.B., Zeng, L.P., Cao, Y.Q., Xiang, J., Luo, X.G., Shi, J.M., Wang, H., et al. (2016). BACE1 in the retina: a sensitive biomarker for monitoring early pathological changes in Alzheimer\u2019s disease. Neural Regen Res. 11: 447\u201353, https:\/\/doi.org\/10.4103\/1673-5374.177732.","DOI":"10.4103\/1673-5374.179057"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_088_w2aab3b7b5b1b6b1ab2b1c88Aa","doi-asserted-by":"crossref","unstructured":"Liao, H., Zhu, Z., and Peng, Y. (2018). Potential utility of retinal imaging for Alzheimer\u2019s disease: a review. Front. Aging Neurosci. 10: 188, https:\/\/doi.org\/10.3389\/fnagi.2018.00188.","DOI":"10.3389\/fnagi.2018.00188"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_089_w2aab3b7b5b1b6b1ab2b1c89Aa","doi-asserted-by":"crossref","unstructured":"Liu, G., and Chen, Z. (2013). Advances in Doppler OCT. Chin. Optic Lett. 11: 11702.","DOI":"10.3788\/COL201311.011702"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_090_w2aab3b7b5b1b6b1ab2b1c90Aa","doi-asserted-by":"crossref","unstructured":"Liu, B., Rasool, S., Yang, Z., Glabe, C.G., Schreiber, S.S., Ge, J., and Tan, Z. (2009). Amyloid-peptide vaccinations reduce {Beta}-Amyloid plaques but exacerbate vascular deposition and inflammation in the retina of Alzheimer\u2019s transgenic mice. Am. J. Pathol. 175: 2099\u2013110, https:\/\/doi.org\/10.2353\/ajpath.2009.090159.","DOI":"10.2353\/ajpath.2009.090159"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_091_w2aab3b7b5b1b6b1ab2b1c91Aa","doi-asserted-by":"crossref","unstructured":"Liu, D., Zhang, L., Li, Z., Zhang, X., Wu, Y., Yang, H., Min, B., Zhang, X., Ma, D., and Lu, Y. (2015). Thinner changes of the retinal nerve fiber layer in patients with mild cognitive impairment and Alzheimer\u2019s disease. BMC Neurol. 15: 14, https:\/\/doi.org\/10.1186\/s12883-015-0268-6.","DOI":"10.1186\/s12883-015-0268-6"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_092_w2aab3b7b5b1b6b1ab2b1c92Aa","unstructured":"L\u00f6ffler, K.U., Edward, D.P., and Tso, M.O. (1995). Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina. Invest. Ophthalmol. Vis. Sci. 36: 24\u201331."},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_093_w2aab3b7b5b1b6b1ab2b1c93Aa","doi-asserted-by":"crossref","unstructured":"London, A., Benhar, I., and Schwartz, M. (2013). The retina as A window to the brain-from eye research to CNS disorders. Nat. Rev. Neurol. 9: 44\u201353, https:\/\/doi.org\/10.1038\/nrneurol.2012.227.","DOI":"10.1038\/nrneurol.2012.227"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_094_w2aab3b7b5b1b6b1ab2b1c94Aa","doi-asserted-by":"crossref","unstructured":"Macgillivray, T., Mcgrory, S., Pearson, T., and Cameron, J.R. (2018). Retinal imaging in early Alzheimer\u2019s disease. In: Perneczky, R. (Ed.). Biomarkers for preclinical Alzheimer\u2019s Disease. Neuromethods, Vol 137. Humana Press, New York, NY, pp. 199\u2013212.","DOI":"10.1007\/978-1-4939-7674-4_14"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_095_w2aab3b7b5b1b6b1ab2b1c95Aa","doi-asserted-by":"crossref","unstructured":"Masland, R.H. (2012). The neuronal organization of the retina. Neuron 76: 266\u2013280, https:\/\/doi.org\/10.1016\/j.neuron.2012.10.002.","DOI":"10.1016\/j.neuron.2012.10.002"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_096_w2aab3b7b5b1b6b1ab2b1c96Aa","doi-asserted-by":"crossref","unstructured":"Mcgrory, S., Cameron, J.R., Pellegrini, E., Warren, C., Doubal, F.N., Deary, I.J., Dhillon, B., Wardlaw, J.M., Trucco, E., and Macgillivray, T.J. (2017). The application of retinal fundus camera imaging in dementia: a systematic review. Alzheimers Dement (Amst). 6: 91\u2013107, https:\/\/doi.org\/10.1016\/j.dadm.2016.11.001.","DOI":"10.1016\/j.dadm.2016.11.001"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_097_w2aab3b7b5b1b6b1ab2b1c97Aa","doi-asserted-by":"crossref","unstructured":"Mckhann, G.M., Knopman, D.S., Chertkow, H., Hyman, B.T., Jack, C.R.JR, Kawas, C.H., Klunk, W.E., Koroshetz, W.J., Manly, J.J., Mayeux, R., et al. (2011). The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the national Institute on aging-alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7: 263\u2013269, https:\/\/doi.org\/10.1016\/j.jalz.2011.03.005.","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_098_w2aab3b7b5b1b6b1ab2b1c98Aa","doi-asserted-by":"crossref","unstructured":"Molitor, R.J., Ko, P.C., and Ally, B.A. (2015). Eye movements in Alzheimer\u2019s disease. J Alzheimers Dis. 44: 1\u201312, https:\/\/doi.org\/10.3233\/jad-141173.","DOI":"10.3233\/JAD-141173"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_099_w2aab3b7b5b1b6b1ab2b1c99Aa","doi-asserted-by":"crossref","unstructured":"Moncaster, J.A., Pineda, R., Moir, R.D., Lu, S., Burton, M.A., Ghosh, J. G., Ericsson, M., Soscia, S.J., Mocofanescu, A., Folkerth, R.D., et al. (2010). Alzheimer\u2019s disease amyloid-beta links lens and brain pathology in down syndrome. PloS One 5: E10659, https:\/\/doi.org\/10.1371\/journal.pone.0010659.","DOI":"10.1371\/journal.pone.0010659"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_100_w2aab3b7b5b1b6b1ab2b1d100Aa","doi-asserted-by":"crossref","unstructured":"More, S.S. and Vince, R. (2015). Hyperspectral imaging signatures detect amyloidopathy in Alzheimer\u2019s mouse retina well before onset of cognitive decline. ACS Chem. Neurosci. 6: 306\u2013315, https:\/\/doi.org\/10.1021\/cn500242z.","DOI":"10.1021\/cn500242z"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_101_w2aab3b7b5b1b6b1ab2b1d101Aa","doi-asserted-by":"crossref","unstructured":"More, S.S., Beach, J.M., McClelland, C., Mokhtarzadeh, A., and Vince, R. (2019). Vivo assessment of retinal biomarkers by hyperspectral imaging: early detection of Alzheimer\u2019s disease. ACS Chem. Neurosci. 10: 4492\u20134501, https:\/\/doi.org\/10.1021\/acschemneuro.9b00331.","DOI":"10.1021\/acschemneuro.9b00331"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_102_w2aab3b7b5b1b6b1ab2b1d102Aa","doi-asserted-by":"crossref","unstructured":"Moschos, M.M., Tagaris, G., Markopoulos, I., Margetis, I., Tsapakis, S., Kanakis, M., and Koutsandrea, C. (2011). Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss. Eur. J. Ophthalmol. 21: 24\u201329, https:\/\/doi.org\/10.5301\/ejo.2010.1318.","DOI":"10.5301\/EJO.2010.1318"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_103_w2aab3b7b5b1b6b1ab2b1d103Aa","doi-asserted-by":"crossref","unstructured":"Ngolab, J., Honma, P., and Rissman, R.A. (2019). Reflections on the utility of the retina as a biomarker for Alzheimer\u2019s disease: a literature review. Neurol Ther. 8: 57\u201372, https:\/\/doi.org\/10.1007\/s40120-019-00173-4.","DOI":"10.1007\/s40120-019-00173-4"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_104_w2aab3b7b5b1b6b1ab2b1d104Aa","doi-asserted-by":"crossref","unstructured":"Ning, A., Cui, J., To, E., Ashe, K.H., and Matsubara, J. (2008). Amyloid-beta deposits lead to retinal degeneration in A mouse model of alzheimer disease. Invest. Ophthalmol. Vis. Sci. 49: 5136\u20135143, https:\/\/doi.org\/10.1167\/iovs.08-1849.","DOI":"10.1167\/iovs.08-1849"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_105_w2aab3b7b5b1b6b1ab2b1d105Aa","doi-asserted-by":"crossref","unstructured":"Nitrini, R. (2010). Preclinical diagnosis of Alzheimer\u2019s disease: prevention or prediction?. Dement Neuropsychol. 4: 259\u2013261, https:\/\/doi.org\/10.1590\/s1980-57642010dn40400002.","DOI":"10.1590\/S1980-57642010DN40400002"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_106_w2aab3b7b5b1b6b1ab2b1d106Aa","doi-asserted-by":"crossref","unstructured":"O\u2019Bryhim, B.E., Apte, R.S., Kung, N., Coble, D., and Van Stavern, G.P. (2018). Association of preclinical alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol. 136: 1242\u20131248.","DOI":"10.1001\/jamaophthalmol.2018.3556"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_107_w2aab3b7b5b1b6b1ab2b1d107Aa","doi-asserted-by":"crossref","unstructured":"Olafsdottir, O.B., Saevarsdottir, H.S., Hardarson, S.H., Hannesdottir, K.H., Traustadottir, V.D., Karlsson, R.A., Einarsdottir, A.B., Jonsdottir, K.D., Stefansson, E., and Snaedal, J. (2018). Retinal oxygen metabolism in patients with mild cognitive impairment. Alzheimers Dement (Amst). 10: 340\u2013345, https:\/\/doi.org\/10.1016\/j.dadm.2018.03.002.","DOI":"10.1016\/j.dadm.2018.03.002"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_108_w2aab3b7b5b1b6b1ab2b1d108Aa","doi-asserted-by":"crossref","unstructured":"Oliveira-Souza, F.G., Deramus, M.L., Van Groen, T., Lambert, A.E., Bolding, M.S., and Strang, C.E. (2017). Retinal changes in the tg-swdi mouse model of Alzheimer\u2019s disease. Neuroscience 354: 43\u201353, https:\/\/doi.org\/10.1016\/j.neuroscience.2017.04.021.","DOI":"10.1016\/j.neuroscience.2017.04.021"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_109_w2aab3b7b5b1b6b1ab2b1d109Aa","doi-asserted-by":"crossref","unstructured":"Ong, Y.T., Hilal, S., Cheung, C.Y., Venketasubramanian, N., Niessen, W.J., Vrooman, H., Anuar, A.R., Chew, M., Chen, C., Wong, T.Y., et al. (2015). Retinal neurodegeneration on optical coherence tomography and cerebral atrophy. Neurosci. Lett. 584: 12\u20136, https:\/\/doi.org\/10.1016\/j.neulet.2014.10.010.","DOI":"10.1016\/j.neulet.2014.10.010"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_110_w2aab3b7b5b1b6b1ab2b1d110Aa","doi-asserted-by":"crossref","unstructured":"Palmqvist, S., Zetterberg, H., Mattsson, N., Johansson, P., Minthon, L., Blennow, K., Olsson, M., and Hansson, O. (2015). Detailed comparison of amyloid PET and CSF biomarkers for identifying early alzheimer disease. Neurology 85: 1240\u20139, https:\/\/doi.org\/10.1212\/wnl.0000000000001991.","DOI":"10.1212\/WNL.0000000000001991"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_111_w2aab3b7b5b1b6b1ab2b1d111Aa","unstructured":"Panegyres, P.K. and Chen, H.Y. (2013). Differences between early and late onset Alzheimer\u2019s disease. Am J Neurodegener Dis 2: 300\u2013306."},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_112_w2aab3b7b5b1b6b1ab2b1d112Aa","doi-asserted-by":"crossref","unstructured":"Paquet, C., Boissonnot, M., Roger, F., Dighiero, P., Gil, R., and Hugon, J. (2007). Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer\u2019s disease. Neurosci. Lett. 420: 97\u201399, https:\/\/doi.org\/10.1016\/j.neulet.2007.02.090.","DOI":"10.1016\/j.neulet.2007.02.090"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_113_w2aab3b7b5b1b6b1ab2b1d113Aa","doi-asserted-by":"crossref","unstructured":"Parisi, V., Restuccia, R., Fattapposta, F., Mina, C., Bucci, M.G., and Pierelli, F. (2001). Morphological and functional retinal impairment in Alzheimer\u2019s disease patients. Clin. Neurophysiol. 112: 1860\u20131871, https:\/\/doi.org\/10.1016\/s1388-2457(01)00620-4.","DOI":"10.1016\/S1388-2457(01)00620-4"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_114_w2aab3b7b5b1b6b1ab2b1d114Aa","doi-asserted-by":"crossref","unstructured":"Park, S.W., Im, S., Jun, H.O., Lee, K., Park, Y.J., Kim, J.H., Park, W.J., Lee, Y.H., and Kim, J.H. (2017). Dry age-related macular degeneration like pathology in aged 5XFAD mice: ultrastructure and microarray analysis. Oncotarget. 8: 40006\u201340018, https:\/\/doi.org\/10.18632\/oncotarget.16967.","DOI":"10.18632\/oncotarget.16967"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_115_w2aab3b7b5b1b6b1ab2b1d115Aa","doi-asserted-by":"crossref","unstructured":"Patton, N., Aslam, T., Macgillivray, T., Pattie, A., Deary, I.J., and Dhillon, B. (2005). Retinal vascular image analysis as A potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J. Anat. 206: 319\u2013348, https:\/\/doi.org\/10.1111\/j.1469-7580.2005.00395.x.","DOI":"10.1111\/j.1469-7580.2005.00395.x"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_116_w2aab3b7b5b1b6b1ab2b1d116Aa","doi-asserted-by":"crossref","unstructured":"Perez, S.E., Lumayag, S., Kovacs, B., Mufson, E.J., and Xu, S. (2009). Beta-amyloid deposition and functional impairment in the retina of the appswe\/PS1DeltaE9 transgenic mouse model of Alzheimer\u2019s disease. Invest. Ophthalmol. Vis. Sci. 50: 793\u2013800, https:\/\/doi.org\/10.1167\/iovs.08-2384.","DOI":"10.1167\/iovs.08-2384"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_117_w2aab3b7b5b1b6b1ab2b1d117Aa","doi-asserted-by":"crossref","unstructured":"Perry, R.J. and Hodges, J.R. (2000). Relationship between functional and neuropsychological performance in early alzheimer disease. Alzheimer Dis. Assoc. Disord. 14: 1\u201310, https:\/\/doi.org\/10.1097\/00002093-200001000-00001.","DOI":"10.1097\/00002093-200001000-00001"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_118_w2aab3b7b5b1b6b1ab2b1d118Aa","doi-asserted-by":"crossref","unstructured":"Pillai, J.A., Bermel, R., Bonner-Jackson, A., Rae-Grant, A., Fernandez, H., Bena, J., Jones, S.E., Ehlers, J.P., and Leverenz, J.B. (2016). Retinal nerve fiber layer thinning in Alzheimer\u2019s disease: a case-control study in comparison to normal aging, Parkinson\u2019s disease, and non-alzheimer\u2019s dementia. Am J Alzheimers Dis Other Demen. 31: 430\u2013436, https:\/\/doi.org\/10.1177\/1533317515628053.","DOI":"10.1177\/1533317515628053"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_119_w2aab3b7b5b1b6b1ab2b1d119Aa","doi-asserted-by":"crossref","unstructured":"Polo, V., Rodrigo, M.J., Garcia-Martin, E., Otin, S., Larrosa, J.M., Fuertes, M.I., Bambo, M.P., Pablo, L.E., and Satue, M. (2017). Visual dysfunction and its correlation with retinal changes in patients with Alzheimer\u2019s disease. Eye 31: 1034\u20131041, https:\/\/doi.org\/10.1038\/eye.2017.23.","DOI":"10.1038\/eye.2017.23"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_120_w2aab3b7b5b1b6b1ab2b1d120Aa","doi-asserted-by":"crossref","unstructured":"Provis, J.M. (2001). Development of the primate retinal vasculature. Prog. Retin. Eye Res. 20: 799\u2013821, https:\/\/doi.org\/10.1016\/s1350-9462(01)00012-x.","DOI":"10.1016\/S1350-9462(01)00012-X"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_121_w2aab3b7b5b1b6b1ab2b1d121Aa","doi-asserted-by":"crossref","unstructured":"Querques, G., Borrelli, E., Sacconi, R., De Vitis, L., Leocani, L., Santangelo, R., Magnani, G., Comi, G., and Bandello, F. (2019). Functional and morphological changes of the retinal vessels in Alzheimer\u2019s disease and mild cognitive impairment. Sci. Rep. 9: 63, https:\/\/doi.org\/10.1038\/s41598-018-37271-6.","DOI":"10.1038\/s41598-018-37271-6"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_122_w2aab3b7b5b1b6b1ab2b1d122Aa","doi-asserted-by":"crossref","unstructured":"Rajmohan, R., and Reddy, P.H. (2017). Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons. J Alzheimers Dis. 57: 975\u2013999, https:\/\/doi.org\/10.3233\/jad-160612.","DOI":"10.3233\/JAD-160612"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_123_w2aab3b7b5b1b6b1ab2b1d123Aa","doi-asserted-by":"crossref","unstructured":"Ratnayaka, J.A., Serpell, L.C., and Lotery, A.J. (2015). Dementia of the eye: the role of amyloid beta in retinal degeneration. Eye 29: 1013\u20131026, https:\/\/doi.org\/10.1038\/eye.2015.100.","DOI":"10.1038\/eye.2015.100"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_124_w2aab3b7b5b1b6b1ab2b1d124Aa","doi-asserted-by":"crossref","unstructured":"Reed, B.T., Behar-Cohen, F., and Krantic, S. (2017). Seeing early signs of Alzheimer\u2019s disease through the lens of the eye. Curr. Alzheimer Res. 14: 6\u201317.","DOI":"10.2174\/1567205013666160819131904"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_125_w2aab3b7b5b1b6b1ab2b1d125Aa","doi-asserted-by":"crossref","unstructured":"Sadda, S.R., Borrelli, E., Fan, W., Ebraheem, A., Marion, K.M., Harrington, M., and Kwon, S. (2019). A pilot study of fluorescence lifetime imaging ophthalmoscopy in preclinical Alzheimer\u2019s disease. Eye 33: 1271\u20131279, https:\/\/doi.org\/10.1038\/s41433-019-0406-2.","DOI":"10.1038\/s41433-019-0406-2"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_126_w2aab3b7b5b1b6b1ab2b1d126Aa","unstructured":"Sadowsky, C.H., Kerbage, C., Tariot, P.N., Agronin, M., Alva, G., Doraiswamy, P.M., Turner, F.D., Nilan, D., Cameron, A., Cagle, G.D., and Hartung, P.D. (2014). Diagnosis of Alzheimer\u2019s disease through the eye and its correlation with cognitive tests and brain imaging. JSM Alzheimer\u2019s Dis Related Dementia. 1: 5."},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_127_w2aab3b7b5b1b6b1ab2b1d127Aa","doi-asserted-by":"crossref","unstructured":"Sadun, A.A., and Bassi, C.J. (1990). Optic nerve damage in Alzheimer\u2019s disease. Ophthalmology 97: 9\u201317, https:\/\/doi.org\/10.1016\/s0161-6420(90)32621-0.","DOI":"10.1016\/S0161-6420(90)32621-0"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_128_w2aab3b7b5b1b6b1ab2b1d128Aa","doi-asserted-by":"crossref","unstructured":"Sadun, A. A., Borchert, M., Devita, E., Hinton, D.R., and Bassi, C.J. (1987). Assessment of visual impairment in patients with Alzheimer\u2019s disease. Am. J. Ophthalmol. 104: 113\u2013120, https:\/\/doi.org\/10.1016\/0002-9394(87)90001-8.","DOI":"10.1016\/0002-9394(87)90001-8"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_129_w2aab3b7b5b1b6b1ab2b1d129Aa","unstructured":"Sadun, A.A. (1989). The optic neuropathy of Alzheimer\u2019s disease. Metab. Pediatr. Syst. Ophthalmol. 12: 64\u201368."},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_130_w2aab3b7b5b1b6b1ab2b1d130Aa","doi-asserted-by":"crossref","unstructured":"Saint-Geniez, M. and D\u2019amore, P.A. (2004). Development and pathology of the hyaloid, choroidal and retinal vasculature. Int. J. Dev. Biol. 48: 1045\u20131058, https:\/\/doi.org\/10.1387\/ijdb.041895ms.","DOI":"10.1387\/ijdb.041895ms"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_131_w2aab3b7b5b1b6b1ab2b1d131Aa","doi-asserted-by":"crossref","unstructured":"Sassi, C., Guerreiro, R., Gibbs, R., Ding, J., Lupton, M.K., Troakes, C., Lunnon, K., Al-Sarraj, S., Brown, K.S., Medway, C., et al. (2014). Exome sequencing identifies 2 novel presenilin 1 mutations (P.L166V and P.S230R) in British early-onset Alzheimer\u2019s disease. Neurobiol. Aging 35: E13\u2013E16, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.06.002.","DOI":"10.1016\/j.neurobiolaging.2014.04.026"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_132_w2aab3b7b5b1b6b1ab2b1d132Aa","doi-asserted-by":"crossref","unstructured":"Schmitz-Valckenberg, S., Brinkmann, C. K., Heimes, B., Liakopoulos, S., Spital, G., Holz, F.G., and Fleckenstein, M. (2017). Pitfalls in retinal OCT imaging. Ophthalmology @ Point Of Care 1, https:\/\/doi.org\/10.5301\/oapoc.0000024.","DOI":"10.5301\/oapoc.0000024"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_133_w2aab3b7b5b1b6b1ab2b1d133Aa","doi-asserted-by":"crossref","unstructured":"Sch\u00f6n, C., Hoffmann, N.A., Ochs, S.M., Burgold, S., Filser, S., Steinbach, S., Seeliger, M.W., Arzberger, T., Goedert, M., Kretzschmar, H.A., et al. (2012). Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. PloS One 7: E53547, https:\/\/doi.org\/10.1371\/journal.pone.0053547.","DOI":"10.1371\/journal.pone.0053547"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_134_w2aab3b7b5b1b6b1ab2b1d134Aa","doi-asserted-by":"crossref","unstructured":"Shah, T.M., Gupta, S.M., Chatterjee, P., Campbell, M., and Martins, R.N. (2017). Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer\u2019s disease. Mol. Psychiatr. 22: 353\u2013363, https:\/\/doi.org\/10.1038\/mp.2016.251.","DOI":"10.1038\/mp.2016.251"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_135_w2aab3b7b5b1b6b1ab2b1d135Aa","doi-asserted-by":"crossref","unstructured":"Sharafi, S.M., Sylvestre, J.-P., Chevrefils, C., Soucy, J.-P., Beaulieu, S., Pascoal, T.A., Arbour, J.D., Rh\u00e9aume, M.-A., Robillard, A., Chayer, C., et al. (2019). Vascular retinal biomarkers improves the detection of the likely cerebral amyloid status from hyperspectral retinal images. Alzheimer\u2019s Dementia 5: 610\u2013617, https:\/\/doi.org\/10.1016\/j.trci.2019.09.006.","DOI":"10.1016\/j.trci.2019.09.006"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_136_w2aab3b7b5b1b6b1ab2b1d136Aa","doi-asserted-by":"crossref","unstructured":"Snyder, P.J., Johnson, L.N., Lim, Y.Y., Santos, C.Y., Alber, J., Maruff, P., and Fern\u00e1ndez, B. (2016). Nonvascular retinal imaging markers of preclinical Alzheimer\u2019s disease. Alzheimers Dement (Amst). 4: 169\u2013178, https:\/\/doi.org\/10.1016\/j.dadm.2016.09.001.","DOI":"10.1016\/j.dadm.2016.09.001"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_137_w2aab3b7b5b1b6b1ab2b1d137Aa","doi-asserted-by":"crossref","unstructured":"Sonkusare, S.K., Kaul, C.L., and Ramarao, P. (2005). Dementia of Alzheimer\u2019s disease and other neurodegenerative disorders\u2013memantine, A new hope. Pharmacol. Res. 51: 1\u201317, https:\/\/doi.org\/10.1016\/j.phrs.2004.05.005.","DOI":"10.1016\/j.phrs.2004.05.005"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_138_w2aab3b7b5b1b6b1ab2b1d138Aa","doi-asserted-by":"crossref","unstructured":"Sperling, R.A., Aisen, P.S., Beckett, L.A., Bennett, D.A., Craft, S., Fagan, A.M., Iwatsubo, T., Jack, C.R., Kaye, J., Montine, T.J., et al. (2011). Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the national Institute on aging-alzheimer\u2019s association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 7: 280\u2013292, https:\/\/doi.org\/10.1016\/j.jalz.2011.03.003.","DOI":"10.1016\/j.jalz.2011.03.003"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_139_w2aab3b7b5b1b6b1ab2b1d139Aa","doi-asserted-by":"crossref","unstructured":"Stef\u00e1nsson, E., Olafsdottir, O.B., Einarsdottir, A.B., Eliasdottir, T.S., Eysteinsson, T., Vehmeijer, W., Vandewalle, E., Bek, T., and Hardarson, S.H. (2017). Retinal oximetry discovers novel biomarkers in retinal and brain diseases. Invest. Ophthalmol. Vis. Sci. 58: Bio227\u2013Bio233, https:\/\/doi.org\/10.1167\/iovs.17-21776.","DOI":"10.1167\/iovs.17-21776"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_140_w2aab3b7b5b1b6b1ab2b1d140Aa","doi-asserted-by":"crossref","unstructured":"Stefani, A., Sancesario, G., Pierantozzi, M., Leone, G., Galati, S., Hainsworth, A.H., and Diomedi, M. (2009). CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer\u2019s and mixed dementia. J. Neurol. Sci. 283: 109\u2013115, https:\/\/doi.org\/10.1016\/j.jns.2009.02.343.","DOI":"10.1016\/j.jns.2009.02.343"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_141_w2aab3b7b5b1b6b1ab2b1d141Aa","unstructured":"Syed, A.B., Armstrong, R.A., and Smith, C.U. (2005). A quantitative analysis of optic nerve axons in elderly control subjects and patients with Alzheimer\u2019s disease. Folia Neuropathol. 43: 1\u20136."},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_142_w2aab3b7b5b1b6b1ab2b1d142Aa","doi-asserted-by":"crossref","unstructured":"Szegedi, S., Dal-Bianco, P., St\u00f6gmann, E., Traub-Weidinger, T., Rainer, M., Masching, A., Schmidl, D., Werkmeister, R.M., Chua, J., Schmetterer, L., and Garh\u00f6fer, G. (2020). Anatomical and functional changes in the retina in patients with Alzheimer\u2019s disease and mild cognitive impairment. Acta Ophthalmol., https:\/\/doi.org\/10.1111\/aos.14419.","DOI":"10.1111\/aos.14419"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_143_w2aab3b7b5b1b6b1ab2b1d143Aa","doi-asserted-by":"crossref","unstructured":"Tan, A.C.S., Tan, G.S., Denniston, A.K., Keane, P.A., Ang, M., Milea, D., Chakravarthy, U., and Cheung, C.M.G. (2018). An overview of the clinical applications of optical coherence tomography angiography. Eye 32: 262\u2013286, https:\/\/doi.org\/10.1038\/eye.2017.181.","DOI":"10.1038\/eye.2017.181"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_144_w2aab3b7b5b1b6b1ab2b1d144Aa","doi-asserted-by":"crossref","unstructured":"Thomson, K.L., Yeo, J.M., Waddell, B., Cameron, J.R., and Pal, S. (2015). A systematic review and meta-analysis of retinal nerve fiber layer change in dementia, using optical coherence tomography. Alzheimers Dement (Amst). 1: 136\u201343, https:\/\/doi.org\/10.1016\/j.dadm.2015.03.001.","DOI":"10.1016\/j.dadm.2015.03.001"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_145_w2aab3b7b5b1b6b1ab2b1d145Aa","doi-asserted-by":"crossref","unstructured":"Trebbastoni, A., D\u2019antonio, F., Bruscolini, A., Marcelli, M., Cecere, M., Campanelli, A., Imbriano, L., Lena, D.E., and Gharbiya, M. (2016). Retinal nerve fibre layer thickness changes in Alzheimer\u2019s disease: results from A 12-month prospective case series. Neurosci. Lett. 629: 165\u2013170, https:\/\/doi.org\/10.1016\/j.neulet.2016.07.006.","DOI":"10.1016\/j.neulet.2016.07.006"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_146_w2aab3b7b5b1b6b1ab2b1d146Aa","doi-asserted-by":"crossref","unstructured":"Trick, G.L., Barris, M.C., and Bickler-Bluth, M. (1989). Abnormal pattern electroretinograms in patients with senile dementia of the alzheimer type. Ann. Neurol. 26: 226\u201331, https:\/\/doi.org\/10.1002\/ana.410260208.","DOI":"10.1002\/ana.410260208"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_147_w2aab3b7b5b1b6b1ab2b1d147Aa","doi-asserted-by":"crossref","unstructured":"Tsai, C.S., Ritch, R., Schwartz, B., Lee, S.S., Miller, N.R., Chi, T., and Hsieh, F.Y. (1991). Optic nerve head and nerve fiber layer in Alzheimer\u2019s disease. Arch. Ophthalmol. 109: 199\u2013204, https:\/\/doi.org\/10.1001\/archopht.1991.01080020045040.","DOI":"10.1001\/archopht.1991.01080020045040"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_148_w2aab3b7b5b1b6b1ab2b1d148Aa","doi-asserted-by":"crossref","unstructured":"Tsai, Y., Lu, B., Ljubimov, A.V., Girman, S., Ross-Cisneros, F.N., Sadun, A. A., Svendsen, C.N., Cohen, R.M., and Wang, S. (2014). Ocular changes in tgf344-AD rat model of Alzheimer\u2019s disease. Invest. Ophthalmol. Vis. Sci. 55: 523\u2013534, https:\/\/doi.org\/10.1167\/iovs.13-12888.","DOI":"10.1167\/iovs.13-12888"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_149_w2aab3b7b5b1b6b1ab2b1d149Aa","doi-asserted-by":"crossref","unstructured":"Van De Kreeke, J.A., Nguyen, H.T., Konijnenberg, E., Tomassen, J., Den Braber, A., Ten Kate, M., Yaqub, M., Van Berckel, B., Lammertsma, A.A., Boomsma, D.I., et al. (2020). Optical coherence tomography angiography in preclinical Alzheimer\u2019s disease. Br. J. Ophthalmol. 104: 157\u2013161, https:\/\/doi.org\/10.1136\/bjophthalmol-2019-314127.","DOI":"10.1136\/bjophthalmol-2019-314127"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_150_w2aab3b7b5b1b6b1ab2b1d150Aa","doi-asserted-by":"crossref","unstructured":"Vergara, M.N. and Canto-Soler, M.V. (2012). Rediscovering the chick embryo as A model to study retinal development. Neural Dev. 7: 22, https:\/\/doi.org\/10.1186\/1749-8104-7-22.","DOI":"10.1186\/1749-8104-7-22"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_151_w2aab3b7b5b1b6b1ab2b1d151Aa","doi-asserted-by":"crossref","unstructured":"Villemagne, V.L., Fodero-Tavoletti, M.T., Masters, C.L., and Rowe, C.C. (2015). Tau imaging: early progress and future directions. Lancet Neurol. 14: 114\u2013124, https:\/\/doi.org\/10.1016\/s1474-4422(14)70252-2.","DOI":"10.1016\/S1474-4422(14)70252-2"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_152_w2aab3b7b5b1b6b1ab2b1d152Aa","doi-asserted-by":"crossref","unstructured":"Walsh, D.M. and Selkoe, D.J. (2007). A beta oligomers - a decade of discovery. J. Neurochem. 101: 1172\u20131184, https:\/\/doi.org\/10.1111\/j.1471-4159.2006.04426.x.","DOI":"10.1111\/j.1471-4159.2006.04426.x"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_153_w2aab3b7b5b1b6b1ab2b1d153Aa","unstructured":"Wang, L.P. and Schmidt, J.F. (1997). Central nervous side effects after lumbar puncture. A review of the possible pathogenesis of the syndrome of postdural puncture headache and associated symptoms. Dan. Med. Bull. 44: 79\u201381."},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_154_w2aab3b7b5b1b6b1ab2b1d154Aa","doi-asserted-by":"crossref","unstructured":"Wegmann, S., Jung, Y.J., Chinnathambi, S., Mandelkow, E.M., Mandelkow, E., and Muller, D.J. (2010). Human tau isoforms assemble into ribbon-like fibrils that display polymorphic structure and stability. J. Biol. Chem. 285: 27302\u201327313, https:\/\/doi.org\/10.1074\/jbc.m110.145318.","DOI":"10.1074\/jbc.M110.145318"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_155_w2aab3b7b5b1b6b1ab2b1d155Aa","doi-asserted-by":"crossref","unstructured":"Wilcockson, T.D.W., Mardanbegi, D., Xia, B., Taylor, S., Sawyer, P., Gellersen, H.W., Leroi, I., Killick, R., and Crawford, T.J. (2019). Abnormalities of saccadic eye movements in dementia due to Alzheimer\u2019s disease and mild cognitive impairment. Aging 11: 5389\u20135398, https:\/\/doi.org\/10.18632\/aging.102118.","DOI":"10.18632\/aging.102118"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_156_w2aab3b7b5b1b6b1ab2b1d156Aa","doi-asserted-by":"crossref","unstructured":"Williams, M.A., Mcgowan, A.J., Cardwell, C.R., Cheung, C.Y., Craig, D., Passmore, P., Silvestri, G., Maxwell, A.P., and Mckay, G.J. (2015). Retinal microvascular network attenuation in Alzheimer\u2019s disease. Alzheimers Dement (Amst). 1: 229\u2013235, https:\/\/doi.org\/10.1016\/j.dadm.2015.04.001.","DOI":"10.1016\/j.dadm.2015.04.001"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_157_w2aab3b7b5b1b6b1ab2b1d157Aa","doi-asserted-by":"crossref","unstructured":"Wilson, R.S., Leurgans, S.E., Boyle, P.A., and Bennett, D.A. (2011). Cognitive decline in prodromal alzheimer disease and mild cognitive impairment. Arch. Neurol. 68: 351\u2013356, https:\/\/doi.org\/10.1001\/archneurol.2011.31.","DOI":"10.1001\/archneurol.2011.31"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_158_w2aab3b7b5b1b6b1ab2b1d158Aa","doi-asserted-by":"crossref","unstructured":"Yang, J., Yang, J., Li, Y., Xu, Y., and Ran, C. (2019). Near-infrared fluorescence ocular imaging (NIRFOI) of Alzheimer\u2019s disease. Mol. Imag. Biol. 21: 35\u201343, https:\/\/doi.org\/10.1007\/s11307-018-1213-z.","DOI":"10.1007\/s11307-018-1213-z"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_159_w2aab3b7b5b1b6b1ab2b1d159Aa","doi-asserted-by":"crossref","unstructured":"Zabel, P., Ka\u0142u\u017cny, J. J., Wi\u0142ko\u015b\u0107-D\u0119bczy\u0144ska, M., G\u0119bska-To\u0142oczko, M., Suwa\u0142a, K., Kucharski, R., and Araszkiewicz, A. (2019). Peripapillary retinal nerve fiber layer thickness in patients with Alzheimer\u2019s disease: a comparison of eyes of patients with Alzheimer\u2019s disease, primary open-angle glaucoma, and preperimetric glaucoma and healthy controls. Med. Sci. Mon. Int. Med. J. Exp. Clin. Res. 25: 1001\u20131008, https:\/\/doi.org\/10.12659\/msm.914889.","DOI":"10.12659\/MSM.914889"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_160_w2aab3b7b5b1b6b1ab2b1d160Aa","doi-asserted-by":"crossref","unstructured":"Zhang, Y.S., Zhou, N., Knoll, B.M., Samra, S., Ward, M.R., Weintraub, S., and Fawzi, A.A. (2019). Parafoveal vessel loss and correlation between peripapillary vessel density and cognitive performance in amnestic mild cognitive impairment and early Alzheimer\u2019s disease on optical coherence tomography angiography. PloS One 14, https:\/\/doi.org\/10.1371\/journal.pone.0214685.","DOI":"10.1371\/journal.pone.0214685"},{"key":"2023040102412667462_j_revneuro-2019-0119_ref_161_w2aab3b7b5b1b6b1ab2b1d161Aa","doi-asserted-by":"crossref","unstructured":"Zhao, H., Chang, R., Che, H., Wang, J., Yang, L., Fang, W., Xia, Y., Li, N., Ma, Q., and Wang, X. (2013). Hyperphosphorylation of tau protein by calpain regulation in retina of Alzheimer\u2019s disease transgenic mouse. Neurosci. Lett. 551: 12\u201316, https:\/\/doi.org\/10.1016\/j.neulet.2013.06.026.","DOI":"10.1016\/j.neulet.2013.06.026"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/revneuro\/31\/8\/article-p883.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2019-0119\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2019-0119\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,2]],"date-time":"2023-04-02T04:57:48Z","timestamp":1680411468000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/revneuro-2019-0119\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":161,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,9,13]]},"published-print":{"date-parts":[[2020,11,18]]}},"alternative-id":["10.1515\/revneuro-2019-0119"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2019-0119","relation":{},"ISSN":["2191-0200","0334-1763"],"issn-type":[{"type":"electronic","value":"2191-0200"},{"type":"print","value":"0334-1763"}],"subject":[],"published":{"date-parts":[[2020,8,17]]}}}